BGS Multi-Cancer & Disease Risk Test
Early risk assessment for 8 common cancers, 2 inflammatory diseases, osteoarthritis
CommercialService Offered
Key Facts
Indication
Early risk assessment for 8 common cancers, 2 inflammatory diseases, osteoarthritis
Phase
Commercial
Status
Service Offered
Company
About BioNexus Gene Lab
BioNexus Gene Lab is a public molecular diagnostics company focused on predictive health through early risk assessment. Its core technology, based on decades of research by its late co-founder, analyzes dynamic RNA signatures in blood to screen for predispositions to major diseases. The company's strategy is to commercialize its BGS test as a service from its Malaysian operational hub, targeting the growing global market for liquid biopsy and preventive personalized medicine.
View full company profile